|
DE4208828A1
|
|
USE OF A CHEMICALLY STABILIZED CHLORITE MATRIX FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV INFECTIONS
|
|
US4851222A
|
|
Method of promoting regeneration of bone marrow
|
|
EP0255145A2
|
|
Use of tetrachlorodecaoxide in ophthalmology
|
|
DE3623255A1
|
|
Pharmaceutical composition for preventing oxidative damage to blood vessels
|
|
DE3600931A1
|
|
Formulation of chlorite matrices in solution
|
|
DE3515748A1
|
|
USE OF ISOTON CHLORITE MATRIX SOLUTION IN TUMOR TREATMENT
|
|
DE3515749A1
|
|
USE OF A STABILIZED CHLORITE MATRIX SOLUTION IN INFECTIOUS CONDITIONS
|
|
DE3515745A1
|
|
AQUEOUS CHLORITE MATRIX SOLUTION
|
|
DE3438966A1
|
|
Preparation for liberating activated oxygen, and its use
|
